medroxyprogesterone has been researched along with Coronary Disease in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (22.22) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 14 (51.85) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bray, P; Cushman, M; Greenland, P; Hendrix, S; Hsia, J; Kooperberg, C; Lloyd-Jones, DM; Pettinger, M; Robinson, J; Rossouw, JE | 1 |
| Rossouw, JE | 1 |
| Hansen, LB; Saseen, JJ | 1 |
| Zhu, WL | 1 |
| Salpeter, S | 1 |
| Bennett, SK; Heldman, AW; Herrington, DM; Ouyang, P; Stewart, KJ; Tardif, JC; Tayback, MA; Thompson, PD; Walsh, MN; Wang, NY | 1 |
| Bray, PF; Herrington, DM; Howard, TD; Sane, DC; Vittinghoff, E | 1 |
| Newton, WP; Richard, D | 1 |
| Ottesen, BS; Skouby, SO; Sørensen, MB | 1 |
| Anderson, PW; Barrett-Connor, E; Collins, P; Cox, DA; Grady, D; Kornitzer, M; Mosca, L; Moscarelli, E; Wenger, NK | 1 |
| Speroff, L | 1 |
| Herrington, DM | 1 |
| Elliott, KK | 1 |
| Herrington, DM; Wells, G | 1 |
| Abdelnoor, M; Abdelonoor, M; Berg, K; Djurovic, S; Hofstad, AE; Os, I; Westheim, A | 1 |
| Furberg, C; Grady, D; Herrington, D; Hulley, S; Hunninghake, D; Khan, S; Vittinghoff, E; Wenger, NK | 1 |
| Kremastinos, DT; Kyriakides, ZS; Melissari, E; Sbarouni, E | 1 |
| Barbour, MM | 1 |
| Jordan, VC | 1 |
| Elmouchi, DA; Grady, D; Herrington, DM; Hlatky, MA; Lin, F; Shlipak, MG | 1 |
| Anthony, MS; Clarkson, TB; Wagner, JD | 1 |
| Bush, TL; Ernster, VL; Huggins, GR; Hulka, BS; Kelsey, JL; Schottenfeld, D | 1 |
| Ramont, CB | 1 |
| Simpson, CF | 1 |
| Asperger, Z | 1 |
| Landau, RL; Poulos, JT | 1 |
| Cali, RW | 1 |
8 review(s) available for medroxyprogesterone and Coronary Disease
| Article | Year |
|---|---|
Effect of postmenopausal hormone therapy on cardiovascular risk.
Topics: Bias; Clinical Trials as Topic; Coronary Disease; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Progesterone Congeners; Risk Factors; Treatment Outcome; Women's Health | 2002 |
The heart and estrogen/progestin replacement study (HERS).
Topics: Clinical Trials as Topic; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone; Progesterone Congeners; Randomized Controlled Trials as Topic; United States; Women's Health | 1998 |
The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?
Topics: Aged; Coronary Disease; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Randomized Controlled Trials as Topic; Treatment Outcome | 1999 |
Hormone replacement therapy should not be used as secondary prevention of coronary heart disease.
Topics: Age Factors; Aged; Aspirin; Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism | 2000 |
Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing.
Topics: Aged; Breast Neoplasms; Cholesterol; Coronary Disease; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Incidence; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2001 |
Benefits and risks of menopausal estrogen and/or progestin hormone use.
Topics: Breast Neoplasms; Coronary Disease; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Osteoporosis; Progesterone Congeners; Risk Factors; Uterine Neoplasms | 1988 |
[Peroral contraceptives and thromboembolism].
Topics: Adult; Blood Group Antigens; Contraceptives, Oral; Coronary Disease; Estrogens; Ethinyl Estradiol; Female; Humans; Intracranial Embolism and Thrombosis; Medroxyprogesterone; Middle Aged; Pregnancy; Puerperal Disorders; Pulmonary Embolism; Stimulation, Chemical; Thromboembolism; Thrombophlebitis; Thrombosis; Triglycerides | 1969 |
The metabolic influence of progestins.
Topics: Aldosterone; Amino Acids; Anabolic Agents; Carbon Dioxide; Clinical Trials as Topic; Contraceptives, Oral; Coronary Disease; Diabetes Mellitus; Electrolytes; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hydroxyprogesterones; Lipid Metabolism; Male; Medroxyprogesterone; Mineralocorticoids; Natriuresis; Nitrogen; Potassium; Pregnancy; Pregnanediol; Progestins; Proteins; Respiration; Respiratory Center | 1971 |
10 trial(s) available for medroxyprogesterone and Coronary Disease
| Article | Year |
|---|---|
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Hysterectomy; Inflammation; Insulin; Integrin beta3; Interleukin-6; Leukocyte Count; Matrix Metalloproteinase 9; Medroxyprogesterone; Middle Aged; Polymorphism, Genetic; Thrombosis; Triglycerides; von Willebrand Factor | 2008 |
[Cardiovascular effects of estrogen in postmenopausal women].
Topics: Arteriosclerosis; Coronary Disease; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Middle Aged; Postmenopause | 2002 |
Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries.
Topics: Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Medroxyprogesterone; Middle Aged; Postmenopause; Retrospective Studies; Saphenous Vein; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2006 |
Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.
Topics: Aged; Alleles; Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Medroxyprogesterone; Membrane Glycoproteins; Membrane Proteins; Mutation; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Postmenopause; Risk Factors; Time Factors; Treatment Outcome | 2007 |
The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?
Topics: Aged; Coronary Disease; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Randomized Controlled Trials as Topic; Treatment Outcome | 1999 |
Increased plasma concentrations of TGF-beta1 after hormone replacement therapy.
Topics: Administration, Cutaneous; Aged; Coronary Disease; Estradiol; Female; Hormone Replacement Therapy; Humans; Lipoprotein(a); Medroxyprogesterone; Middle Aged; Postmenopause; Progesterone Congeners; Radiography; Risk Factors; Transforming Growth Factor beta; Treatment Outcome | 2000 |
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Topics: Aged; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Hospitalization; Humans; Leg Injuries; Medroxyprogesterone; Multivariate Analysis; Neoplasms; Proportional Hazards Models; Pulmonary Embolism; Risk Factors; Surgical Procedures, Operative; Venous Thrombosis | 2000 |
Effects of simvastatin or hormone replacement therapy, or both, on fibrinogen, factor VII, and plasminogen activator inhibitor levels in postmenopausal women with proven coronary artery disease.
Topics: Anticholesteremic Agents; Antigens; Biomarkers; Coronary Disease; Cross-Over Studies; Drug Therapy, Combination; Estrogens, Conjugated (USP); Factor VII; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Hypercholesterolemia; Medroxyprogesterone; Middle Aged; Plasminogen Inactivators; Postmenopause; Progesterone Congeners; Simvastatin | 2000 |
The incidence of unrecognized myocardial infarction in women with coronary heart disease.
Topics: Aged; Coronary Disease; Double-Blind Method; Electrocardiography; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone; Myocardial Infarction; Postmenopause; Progesterone Congeners; Risk Factors | 2001 |
The metabolic influence of progestins.
Topics: Aldosterone; Amino Acids; Anabolic Agents; Carbon Dioxide; Clinical Trials as Topic; Contraceptives, Oral; Coronary Disease; Diabetes Mellitus; Electrolytes; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hydroxyprogesterones; Lipid Metabolism; Male; Medroxyprogesterone; Mineralocorticoids; Natriuresis; Nitrogen; Potassium; Pregnancy; Pregnanediol; Progestins; Proteins; Respiration; Respiratory Center | 1971 |
11 other study(ies) available for medroxyprogesterone and Coronary Disease
| Article | Year |
|---|---|
What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
Topics: Adult; Aged; Breast Neoplasms; Coronary Disease; Endpoint Determination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Pharmacists; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Assessment; Treatment Outcome | 2003 |
Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Topics: Age Factors; Aged; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Risk Assessment; Women's Health | 2005 |
Hormone replacement therapy to prevent coronary events.
Topics: Aged; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Factors | 1998 |
[Post-menopausal hormone substitution and ischemic heart disease].
Topics: Aged; Controlled Clinical Trials as Topic; Coronary Disease; Estrogen Replacement Therapy; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Middle Aged; Postmenopause; Progesterone Congeners | 1999 |
Coronary heart disease in women, randomized clinical trials, HERS and RUTH.
Topics: Coronary Disease; Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Meta-Analysis as Topic; Piperidines; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Women's Health | 1998 |
The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study.
Topics: Clinical Trials as Topic; Confounding Factors, Epidemiologic; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Patient Dropouts; Postmenopause; Risk Factors; Time Factors | 1999 |
Hormone replacement therapy and risk of heart disease.
Topics: Coronary Disease; Equilin; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Progesterone Congeners | 1999 |
A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys.
Topics: Animals; Antineoplastic Agents, Hormonal; Apolipoproteins; Arteriosclerosis; Body Weight; Bone Density; Cholesterol, HDL; Coronary Disease; Estradiol; Estrogens; Estrone; Female; Horses; Lipoproteins; Macaca fascicularis; Medroxyprogesterone; Norpregnenes; Postmenopause; Progesterone Congeners | 2001 |
Cyclic hormonetherapy. A report on 305 cases.
Topics: Adult; Aged; Breast Neoplasms; Coronary Disease; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis; Uterine Neoplasms; Vaginal Smears | 1966 |
Effects of estrogen and progestogen on the cardiovascular and endocrine systems of turkeys.
Topics: Animals; Aortic Aneurysm; Aortic Diseases; Arteriosclerosis; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Coronary Disease; Diethylstilbestrol; Endocrine System Diseases; Female; Heart Rate; Hypothyroidism; Male; Medroxyprogesterone; Mestranol; Ovary; Poultry Diseases; Rupture, Spontaneous; Testis; Triglycerides; Turkeys | 1973 |
Management of the climacteric and postmenopausal woman.
Topics: Aged; Anxiety; Climacteric; Coronary Disease; Depression; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasms; Osteoporosis; Ovary; Psychophysiologic Disorders; Vaginitis; Vasomotor System | 1972 |